2 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Glomerular Disease: new trials by email Literature Review of Glomerular Disease trials Research Report on Glomerular Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of HS-10542 for IgA Nephropathy HS-10542 High Dose, HS-10542 Low Dose, Placebo - IgAN, Immunoglobulin A Nephropathy (IgAN) | Phase 2 | Not yet recruiting | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 90 | 2026-03-17 | 2026-03-16 |
| Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease ANG-3070, Placebo - Glomerular Disease, Proteinuria | Phase 2 | Unknown | Angion Biomedica Corp | 100 | 2021-12-24 | 2022-03-23 |
| Safety and Efficacy Study of VIS649 for IgA Nephropathy Dose-Placebo, Low Dose-VIS649, Medium Dose-VIS649 - Immunoglobulin A Nephropathy, Glomerular Disease | Phase 2 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 155 | 2020-07-20 | 2026-04-24 |
| Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy Rituximab Infusion, Oral Cyclosporine - Nephrotic Syndrome, Proteinuria | Phase 2 | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 30 | 2010-12-22 | 2026-10-26 |
| TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis) TRK-100STP high dose, TRK-100STP low dose, Placebo - Chronic Renal Failure, Glomerular Disease | Phase 2 / Phase 3 | Completed | Toray Industries, Inc | 892 | 2010-03-01 | 2015-02-04 |
Proteinuria (3) · Autoimmune Diseases (2) · Glomerulonephritis, IGA (2) · Kidney Diseases (2) · Glomerulonephritis (1) · Glomerulonephritis, Membranous (1) · Immune System Diseases (1) · Kidney Failure, Chronic (1) · Nephritis (1) · Nephrosclerosis (1) · Nephrotic Syndrome (1) · Renal Insufficiency, Chronic (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Male Urogenital Diseases (5) · Urogenital Diseases (5) · Urologic Diseases (5) · Pathological Conditions, Signs and Symptoms (4) · Kidney Diseases (3) · Signs and Symptoms (3) · Urination Disorders (3) · Urological Manifestations (3) · Chronic Disease (2) · Disease Attributes (2) · Glomerulonephritis (2) · Immune System Diseases (2) · Nephritis (2)
Cyclosporine (1)
Angion Biomedica Corp (1) · Jiangsu Hansoh Pharmaceutical Co., Ltd. (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Otsuka Pharmaceutical Development & Commercialization, Inc. (1) · Toray Industries, Inc (1)
United States (3) · Australia (2) · China (2) · Hong Kong (2) · Japan (2) · Malaysia (2) · South Korea (2) · Taiwan (2) · Thailand (2) · Canada (1) · Georgia (1) · India (1) · Philippines (1) · Singapore (1) · Spain (1)
Asher Schachter, M.D. (1) · John Neylan, MD (1) · Meryl A Waldman, M.D. (1)
PMID 25233856, PMID 35224730, PMID 36821613, PMID 37916620, PMID 38299639, PMID 42275148
2019 (1)